Ceftiofur Sodium
Ceftiofur sodium is a **veterinary-specific, third-generation cephalosporin** antibiotic. It is widely utilized across multiple species for its broad-spectrum efficacy against both gram-positive and gram-negative bacteria. **Key Clinical Highlights:** * **Primary Indications:** Highly effective for bovine and swine respiratory diseases, foot rot in cattle, and susceptible urinary tract infections (UTIs) and soft tissue infections in dogs and cats. * **Extra-label Use:** Frequently used off-label in exotic species (including reptiles, ratites, and elephants) and for various systemic infections in small animals. * **Safety Profile:** Generally safe, but can cause transient pain upon intramuscular (IM) injection. It carries a risk of hypersensitivity reactions, and caution is advised in patients with known beta-lactam allergies. * **Metabolism:** Rapidly converted in vivo to its active metabolite, desfuroylceftiofur, which maintains potent antibacterial activity.
กลไกการออกฤทธิ์: Ceftiofur is a **time-dependent, bactericidal** antibiotic. Upon administration, ceftiofur is rapidly cleaved → **furoic acid** and **desfuroylceftiofur** (the primary active metabolite). Desfuroylceftiofur → binds to **penicillin-binding proteins (PBPs)** located inside the bacterial cell wall → inhibits the third and final stage of bacterial cell wall synthesis by halting peptidoglycan cross-linking → weakens the structural integrity of the cell wall → leads to **cell lysis** and bacterial death.
ขนาดยาตามชนิดสัตว์
- Respiratory disease · 1.1 to 2.2 mg/kg · IM · q24h · 3-5 days · 1-2 mL reconstituted sterile solution per 100 lbs body weight
- Respiratory disease · 1.1 to 2.2 mg/kg · IM · q24h · 3-5 days · When used in lactating does, the high end of the dosage is recommended
- UTI · 2.2 mg/kg · SC · q24h · 5-14 days
- Systemic, soft tissue infections · 2.2 mg/kg q12h or 4.4 mg/kg q24h · SC · q12h or q24h · 5-14 days
- Sepsis, bacteremia · 4.4 mg/kg · SC · q12h · 2-5 days
- Bovine respiratory disease, foot rot · 1.1 to 2.2 mg/kg · IM or SC · q24h · 3-5 days · 1-2 mL reconstituted sterile solution per 100 lbs body weight
- Respiratory infections (S. zooepidemicus) · 2.2 to 4.4 mg/kg · IM · q24h · up to 10 days · Continue for 48 hours after symptoms disappear. Max 10 mL per injection site.
- General susceptible infections · 1-2 mg/kg · IV or IM · q12-24h
วิธีการให้ยา
ข้อห้ามใช้
- Patients with a history of hypersensitivity to cephalosporins
- Caution in patients with documented hypersensitivity to other beta-lactam antibiotics (penicillins, cefamycins, carbapenems)
อาการไม่พึงประสงค์
- Immediate and transient local pain on IM injection
- Discoloration at SC injection sites (may persist >5 days)
- Localized post-injection bacterial infections/abscesses (cattle)
- Hypersensitivity reactions (rashes, fever, eosinophilia, lymphadenopathy, anaphylaxis)
- Acute diarrhea (especially in stressed horses)
- Granulocytopenia
- Thrombocytopenia
อันตรกิริยาระหว่างยา
- Aminoglycosides · Potential for additive nephrotoxicity; in vitro synergy exists, but drugs should not be mixed in the same syringe/fluid line.
- Nephrotoxic drugs (e.g., Amphotericin B) · Potential for additive nephrotoxicity.
- Probenecid · Competitively blocks the tubular secretion of most cephalosporins, increasing serum levels and serum half-lives.
การติดตาม
- Clinical efficacy (resolution of infection signs)
- Weekly CBC in small animals (recommended by some clinicians)
- Intensified renal monitoring in patients with diminished renal function
การได้รับยาเกินขนาด
Cephalosporin overdoses are generally well-tolerated and unlikely to cause significant systemic toxicity. * **Clinical Signs:** Primarily limited to gastrointestinal distress (nausea, vomiting, diarrhea) or localized injection site reactions. * **Food Animal Considerations:** Overdoses in food-producing animals may result in significantly extended tissue withdrawal times. Contact FARAD for specific guidance on withdrawal interval adjustments.
ข้อมูลอ้างอิงยาของ VetSheet มีไว้สำหรับสัตวแพทย์ผู้มีใบอนุญาตเพื่อช่วยในการตัดสินใจทางคลินิก ไม่ใช่สิ่งทดแทนการวินิจฉัยของผู้เชี่ยวชาญหรือฉลากล่าสุดของผู้ผลิต